JPK Instruments appoints Bucher Biotec for Swiss market
April 28, 2009
JPK Instruments, a world leading manufacturer of nanoanalytic instrumentation for research in life sciences and soft matter, has appointed leading Swiss company, Bucher Biotec AG as their exclusive representatives in Switzerland. Bucher Biotec AG is a privately held, well established Swiss distributor company representing major US, European and Japanese manufacturers of scientific instruments and associated [...]
Sigma-Aldrich Introduces MISSION(R) esiRNA for Low Cost, High Specificity Pooled RNAi Screening
April 28, 2009
ST. LOUIS, April 28 -- Sigma-Aldrich (Nasdaq: SIAL - News) today announced the global release of MISSION® esiRNA, a pool of gene-specific siRNA that provides a novel and powerful approach to RNAi screening in mammalian cells. Unlike traditional synthetic RNAi, esiRNA (https://www.sigma.com/esirna) incorporates a pool of hundreds of siRNAs against a single gene target. This [...]
Rapid Mouse-Monoclonal Isotyping Kits…
April 28, 2009
AMSBIO (www.amsbio.com) has announced the Iso-Gold™ Rapid Mouse Monoclonal isotyping kits. Iso-Gold is a rapid-format isotyping kit that reduces the labour of the traditional ELISA protocol from a day-and-a-half procedure to a 5-minute assay. Determining the class and subclass of a monoclonal antibody is valuable in selecting the best immunoglobulin purification method. The Iso-Gold kit [...]
April 28, 2009
LILLE, France--At the 15th Annual Society for Biomolecular Sciences (SBS) Conference today, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, and Cerep SA, a leading provider of drug candidate screening and profiling technologies, announced the expansion of their kinase assay offering. Close to 200 new kinase assays [...]
Dr. Harvey E. Bale, Jr. Joins InfraTrac Board of Advisors to Combat Drug Counterfeiting
April 28, 2009
SILVER SPRING, Md.--InfraTrac, a product protection company with innovative anti-counterfeiting technology, announced the appointment of Dr. Harvey E. Bale, Jr., recently retired from the position of Director-General of the Geneva-based International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), to its Board of Advisors. Dr. Bale is widely recognized as a leader in the fight against [...]
AnaSpec Launches New Headquarters in Fremont, California
April 28, 2009
FREMONT, Calif.--Today AnaSpec announced the launch of its new headquarters in Fremont, California. Rapidly expanding over the past 16 years, AnaSpec has graduated to a state-of-the-art facility designed from the ground up for the very highest levels of lab and R&D production. The 44,010 square foot facility offers all top of the line lab/R&D equipment [...]
April 28, 2009
1290 Infinity LC Offers Best-in-Class Specifications in All HPLC, UHPLC and LC/MS Categories WALDBRONN, Germany--Agilent Technologies Inc. (NYSE:A) today introduced the Agilent 1290 Infinity Liquid Chromatography System, designed to deliver significantly greater power, speed and sensitivity for enhanced performance in the high-end Ultra High Performance Liquid Chromatography (UHPLC) market. “The debate about UHPLC is over,” [...]
QIAGEN Provides Solutions for Swine Flu Surveillance
April 28, 2009
Viral sequence analysis suggests that two of the company’s screening tests identify currently spreading H1N1 subtype VENLO, The Netherlands--QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that two of its tests can be used to screen for the swine flu virus which increasingly affects humans in countries around the globe. Data analysis of the [...]
April 28, 2009
FREMONT, Calif., April 28 -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS - News), a leading developer of state-of-the-art genetic analysis systems, today announced the signing of a research collaboration with Duke University Medical Center scientists for WaferGen's SmartChip(TM) Real-Time PCR System. Under terms of the collaboration, the laboratory of Drs. John A. Olson, Jr., [...]
Perlegen Builds Commercial Group to Support Upcoming MammaPLUS™ Launch
April 28, 2009
Industry Veterans Will Introduce Breast Cancer Risk Stratifier to Help Physicians Determine Monitoring and Treatment Plans for Women with Intermediate Levels of Risk MOUNTAIN VIEW, Calif.--Perlegen Sciences, which develops genetic tests that correlate genetic variation to predisposition to disease and drug response, announced today that it has added key positions to its commercial team in [...]

